Treatment of Candida Vaginitis
For uncomplicated vulvovaginal candidiasis (VVC), either a single oral dose of fluconazole 150 mg or a short course of topical azole therapy is recommended as first-line treatment, with both approaches achieving >90% response rates. 1
Diagnosis
Accurate diagnosis is essential before initiating treatment:
- Clinical presentation: Pruritus, erythema in vulvovaginal area, white discharge
- Laboratory confirmation:
Treatment Algorithm
1. Uncomplicated VVC (First Episode or Infrequent Episodes)
Option A: Oral Treatment
- Fluconazole 150 mg as a single oral dose 1, 3
- Achieves 80-90% cure rates
- Convenient single-dose regimen
- Clinical trials show comparable efficacy to topical treatments 4
Option B: Topical Azole Treatments
- Intravaginal formulations:
- Butoconazole 2% cream for 3 days
- Clotrimazole 1% cream for 7-14 days or 100 mg vaginal tablet for 7 days
- Clotrimazole 100 mg vaginal tablet, two tablets for 3 days
- Clotrimazole 500 mg vaginal tablet, single application
- Miconazole 2% cream for 7 days or 200 mg suppository for 3 days
- Tioconazole 6.5% ointment, single application
- Terconazole 0.4% cream for 7 days or 0.8% cream for 3 days 2
2. Complicated VVC
Severe Acute VVC:
- Topical therapy for 7-14 days OR
- Fluconazole 150 mg every 72 hours for 3 doses 1
Recurrent VVC (≥4 episodes in 12 months):
- Initial intensive therapy with fluconazole 150 mg every 72 hours for 3 doses
- Followed by maintenance therapy with fluconazole 150 mg weekly for 6 months 1, 5
Non-albicans Candida species:
- C. glabrata often doesn't respond to standard azole therapy
- Alternative options include boric acid, nystatin, or flucytosine cream 1, 6
Special Populations
Pregnancy
- Only topical azole therapies should be used
- Recommended options: clotrimazole, miconazole, butoconazole, terconazole
- Treatment duration should be 7 days during pregnancy 2, 1
- Fluconazole is contraindicated due to potential risk of spontaneous abortion and birth defects 1
HIV Infection
- Women with HIV infection should receive the same treatment as those without HIV
- VVC in HIV-positive women responds similarly to standard treatment regimens 2, 1
Important Considerations
- OTC preparations should only be used by women previously diagnosed with VVC who experience identical symptoms 2, 1
- Women whose symptoms persist after OTC treatment or who experience recurrence within 2 months should seek medical care 2
- Identifying Candida in asymptomatic women should not lead to treatment (10-20% of women normally harbor Candida) 2
- Oil-based creams and suppositories may weaken latex condoms and diaphragms 2
- Treatment success for recurrent VVC is enhanced by maintenance therapy with weekly oral fluconazole for up to 6 months 5
Treatment Efficacy
Clinical trials have demonstrated that both oral fluconazole and topical azoles achieve 80-90% cure rates 1, 4. A comparative study showed that a single 150 mg oral dose of fluconazole was as effective as 7 days of intravaginal clotrimazole therapy, with clinical cure rates of 94% and 97% respectively at 14 days post-treatment 4.